BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2859185)

  • 1. Antihypertensive effect of felodipine combined with beta-blockade. A comparison between 2 and 3 daily dosages.
    Hansson BG; Lyngstam G; Lyngstam O; Rydén L; Thilén U
    Drugs; 1985; 29 Suppl 2():131-6. PubMed ID: 2859185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension.
    Collste P; Danielsson M; Elmfeldt D; Feleke E; Gelin A; Hedner T; Rydén L
    Drugs; 1985; 29 Suppl 2():124-30. PubMed ID: 2859184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE
    Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trial of felodipine and nifedipine in refractory hypertension.
    Aberg H; Lindsjö M; Mörlin B
    Drugs; 1985; 29 Suppl 2():117-23. PubMed ID: 3886357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of felodipine compared with placebo.
    Elmfeldt D; Hedner T
    Drugs; 1985; 29 Suppl 2():109-16. PubMed ID: 2859183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.
    Br J Clin Pharmacol; 1988 Nov; 26(5):535-45. PubMed ID: 2905154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group.
    Br J Clin Pharmacol; 1986 Jun; 21(6):621-6. PubMed ID: 2874821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension.
    Elmfeldt D; Hedner T
    Eur J Clin Pharmacol; 1983; 25(5):571-5. PubMed ID: 6141051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy.
    Hansson L; Dahlöf B; Gudbrandsson T; Hellsing T; Kullman S; Kuylenstierna J; Leppert J; Möller B; Skogström K; Svensson A
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):94-101. PubMed ID: 2459541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of felodipine and nifedipine as monotherapies for the treatment of mild to moderate hypertension.
    Abelardo NS; Ramos EF; Mendoza VL; Sulit YQ; Mitchell MJ
    J Hum Hypertens; 1989 Feb; 3(1):57-9. PubMed ID: 2657058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felodipine versus Moduretic. A double-blind parallel-group multicentre study.
    Krönig B; Flygt G
    Drugs; 1987; 34 Suppl 3():162-9. PubMed ID: 3327677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG; Leenen FH; Tanner J
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.
    Dahlöf B; Degl' Innocenti A; Elmfeldt D; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Tanser P; Toutouzas P; Waeber B; Wiklund I
    Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study.
    Bonaduce D; Canonico V; Petretta M; Forgione L; Ianniciello A; Cavallaro V; Bertocchi F; Rengo F
    Eur J Clin Pharmacol; 1997; 53(2):95-100. PubMed ID: 9403278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy?
    Waeber B; Detry JM; Dahlöf B; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Safar M; Tanser P; Toutouzas P
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):915-20. PubMed ID: 10509550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of felodipine and propranolol as additions to hydrochlorothiazide in the treatment of hypertension.
    Carle WK; Latta D; Lees CT; Lough JR; Pender J; Ross JR; Sefton S; Peers EM; Richardson PD
    Eur J Clin Pharmacol; 1988; 34(2):115-8. PubMed ID: 3289947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of felodipine, a new dihydropyridine, in hypertension.
    Andersson O; Bengtsson C; Elmfeldt D; Haglund K; Hedner T; Seideman P; Sjöberg KH; Strömgren E; Aberg H; Ostman J
    Br J Clin Pharmacol; 1984 Mar; 17(3):257-63. PubMed ID: 6712859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.